Results 241 to 250 of about 217,907 (337)
Exploring Childhood Lower Urinary Tract Symptoms (LUTS), Urinary Tract Infections (UTIs) and the Microbiome-A Systematic Review. [PDF]
Van den Ende M+4 more
europepmc +1 more source
A 60‐year‐old man with lower urinary tract symptoms [PDF]
Zara Gall, Ann Crump, Ian Pearce
openalex +1 more source
Association between air pollution exposure and lower urinary tract symptoms in Korean men. [PDF]
Jee YM+7 more
europepmc +1 more source
Liver Disease Predicts 30‐Day Postoperative Complications in Head and Neck Microvascular Surgery
While liver disease is known to affect surgical outcomes, its impact on head and neck microvascular free tissue transfer surgeries remains unexamined. This study uses the NSQIP national database to analyze the relationship between liver disease severity, determined by APRI and MELD‐Na scores, and postoperative complications.
Anish R. Kosanam+4 more
wiley +1 more source
Financial Strain Across 25 years and Men's Lower Urinary Tract Symptoms: A Life Course Perspective. [PDF]
Brady SS+8 more
europepmc +1 more source
Abstract Background Levodopa–entacapone–carbidopa intestinal gel (LECIG) was introduced in 2018 as a device‐aided therapy for advanced Parkinson's disease (PD). Objectives The ELEGANCE study (NCT05043103) is gathering real‐world data on long‐term efficacy, safety and patient‐reported outcomes with LECIG from 13 European countries.
Daniel Weiss+10 more
wiley +1 more source
ICI-RS 2015 : is a better understanding of sleep the key in managing nocturia? [PDF]
Cherian, Jerald+8 more
core +2 more sources
Video Urodynamic Study in Patients with Parkinson's Disease and Multiple System Atrophy
Abstract Background Most studies have analyzed the urodynamic characteristics of patients with Parkinson's disease (PD) and multiple system atrophy (MSA) using conventional urodynamic studies. Objectives This study investigated the urodynamic characteristics of both diseases using video urodynamic study (VUDS).
Hyun Sik Yoon+3 more
wiley +1 more source
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin+8 more
wiley +1 more source